CHIMERIC THERAPEUTICS
Chimeric Therapeutics is a company developing ground-breaking CAR T cell therapies for solid tumors based on research at the City of Hope Cancer Centre in Los Angeles. The technology known as CLTX-CAR T, uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor targeting component of the CAR to reprogram T cells and is currently undergoing Phase 1 clinical trials at City of Hope in glioblastoma.
CHIMERIC THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2020-01-01
Address:
Carlton South, Victoria, Australia
Country:
Australia
Website Url:
http://www.chimerictherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+61 3 98245254
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag
Similar Organizations
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.chimerictherapeutics.com Semrush global rank: 5.09 M Semrush visits lastest month: 1.61 K
- Host name: 183.116.180.107.host.secureserver.net
- IP address: 107.180.116.183
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Chimeric Therapeutics" on Search Engine
About us – Chimeric Therapeutics
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular …See details»
Chimeric Therapeutics - Crunchbase Company Profile & Funding
Company Type For Profit. Contact Email [email protected]. Phone Number +61 3 98245254. Chimeric Therapeutics is a company developing ground-breaking …See details»
Chimeric Therapeutics | LinkedIn
Chimeric Therapeutics is the ASX leader in cell therapy. As the only clinical stage, cell therapy biotechnology company in Australia, our focus is on discovering, developing and …See details»
Annual Report - Chimeric Therapeutics
Jun 30, 2021 Chimeric Therapeutics is led by a team of cell therapy pioneers and experts who have workedn o the development of over 25 cell therapies, including 4/ 5 of the …See details»
CHIMERIC THERAPEUTICS ANNOUNCES FDA CLEARANCE …
Oct 31, 2023 Chimeric Therapeutics (ASX:CHM, "Chimeric" or the "Company"), an Australian leader in cell therapy, announced today that the U.S. Food and Drug …See details»
CHIMERIC THERAPEUTICS ANNOUNCES FDA CLEARANCE …
SYDNEY, Oct. 31, 2023 /PRNewswire/ -- Chimeric Therapeutics (ASX:CHM, "Chimeric" or the "Company"), an Australian leader in cell therapy, announced today that the U.S. …See details»
Chimeric Therapeutics Limited investor hub | ASX:CHM
May 2, 2024 Welcome to the Chimeric Therapeutics Limited investor hub. Be the first to get notified about Chimeric Therapeutics Limited news, updates, and announcements. …See details»
Chimeric enters strategic manufacturing partnership with
Apr 12, 2022 MELBOURNE, Australia, April 11, 2022 (GLOBE NEWSWIRE) -- Chimeric Therapeutics (ASX:CHM, “Chimeric”) a clinical-stage cell therapy company and an …See details»
Chimeric Therapeutics Company Profile - Craft
May 9, 2024 Overview. Chimeric Therapeutics is a clinical-stage cell therapy company. It offers NK and T cell-derived allogeneic therapies, clinical trials, and other services for …See details»
Chimeric Therapeutics To Attend BIO International Convention
Jun 5, 2023 SYDNEY, Australia and NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- Chimeric Therapeutics (ASX: CHM) (“Chimeric Therapeutics”, “Chimeric” or the …See details»
Chimeric Therapeutics and OncoBay Clinical Form Partnership to …
OncoBay Clinical is a boutique clinical research organization (CRO) that is a subsidiary of the Moffitt Cancer Center and has extensive experience in cell therapy development. …See details»
Chimeric Therapeutics - BIO International Convention | BIO
Jun 5, 2023 Chimeric Therapeutics is a clinical stage cell therapy company with encouraging early clinical data in Glioblastoma with CHM 1101 and in HR-MDS/ AML …See details»
First AML Patient Treated in Chimeric's CHM 0201 Trial
Feb 8, 2024 Cell therapy company Chimeric Therapeutics (ASX:CHM) has announced that the first patient in the ADVENT-AML Phase 1B clinical trial in Acute Myeloid …See details»
Our Pipeline – Chimeric Therapeutics
Our Pipeline – Chimeric Therapeutics. Building a pipeline to bring the promise of cell therapies to more patients. Clinical Trials. CHM 1101 (CLTX CAR T) PHASE 1B MULTI …See details»
News and Events – Chimeric Therapeutics
Jun 29, 2023 Chimeric Therapeutics Announces FDA Clearance of IND Application for CHM 2101, A Novel CDH17 CAR T Cell Therapy for Advanced Gastrointestinal Cancers. …See details»
Chimeric Therapeutics - Contacts, Employees, Board Members, …
Organization. Chimeric Therapeutics. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 3. …See details»
Here's Why We're A Bit Worried About Chimeric Therapeutics' …
Aug 13, 2022 Given this risk, we thought we'd take a look at whether Chimeric Therapeutics shareholders should be worried about its cash burn. In this article, we …See details»
CHM 2101 - AdisInsight - Springer
Dec 6, 2023 01 Nov 2023 US FDA approves IND application for CHM 2101 in Gastrointestinal cancer. 26 Sep 2023 Chimeric Therapeutics plans phase-I/II trial for …See details»
Fighting lymphoma: Treatment options include alternatives to ...
3 days ago There were roughly a half-million new cases of non-Hodgkin lymphoma and 82,409 new cases of Hodgkin lymphoma in 2022, making them the 10 th and 26 th most …See details»
Chimeric Therapeutics jobs - Indeed
48 Chimeric Therapeutics jobs available on Indeed.com. Apply to Scientist, Development Director, Executive Assistant and more!See details»